- Home
- ACNT vs AGEN Comparison
ACNT vs AGEN Comparison
Compare ACNT & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACNT
- AGEN
- Stock Information
- Founded
- ACNT 1945
- AGEN 1994
- Country
- ACNT United States
- AGEN United States
- Employees
- ACNT N/A
- AGEN N/A
- Industry
- ACNT Steel/Iron Ore
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ACNT Industrials
- AGEN Health Care
- Exchange
- ACNT Nasdaq
- AGEN Nasdaq
- Market Cap
- ACNT 122.5M
- AGEN 142.8M
- IPO Year
- ACNT N/A
- AGEN 2000
- Fundamental
- Price
- ACNT $12.36
- AGEN $4.53
- Analyst Decision
- ACNT
- AGEN Buy
- Analyst Count
- ACNT 0
- AGEN 2
- Target Price
- ACNT N/A
- AGEN $14.50
- AVG Volume (30 Days)
- ACNT 59.3K
- AGEN 387.3K
- Earning Date
- ACNT 11-11-2025
- AGEN 11-11-2025
- Dividend Yield
- ACNT N/A
- AGEN N/A
- EPS Growth
- ACNT N/A
- AGEN N/A
- EPS
- ACNT N/A
- AGEN N/A
- Revenue
- ACNT $172,594,000.00
- AGEN $101,706,000.00
- Revenue This Year
- ACNT $22.72
- AGEN $60.49
- Revenue Next Year
- ACNT N/A
- AGEN N/A
- P/E Ratio
- ACNT N/A
- AGEN N/A
- Revenue Growth
- ACNT 33.04
- AGEN N/A
- 52 Week Low
- ACNT $8.16
- AGEN $1.38
- 52 Week High
- ACNT $13.70
- AGEN $7.34
- Technical
- Relative Strength Index (RSI)
- ACNT 50.06
- AGEN 47.60
- Support Level
- ACNT $12.03
- AGEN $4.36
- Resistance Level
- ACNT $12.80
- AGEN $4.68
- Average True Range (ATR)
- ACNT 0.33
- AGEN 0.26
- MACD
- ACNT 0.06
- AGEN 0.04
- Stochastic Oscillator
- ACNT 52.69
- AGEN 39.09
About ACNT Ascent Industries Co.
Ascent Industries Co is engaged in the chemical and metal industry. The group operates into two reportable segments namely the Specialty Chemicals and Tubular Products. The Tubular Products segment serves markets through pipe and tube and customers in the appliance, architectural, automotive, and commercial transportation, brewery, chemical, petrochemical, and other industries. The Specialty Chemicals segment produces specialty products for pulp and paper, coatings, adhesives, sealants, and elastomers (CASE), textile, automotive, household, and other industries. It manufactures welded pipe and tube, majorly from stainless steel, duplex, and nickel alloys. The company also produces specialty chemicals and dyes used in various end markets.
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).